AlloVir (ALVR) to Release Quarterly Earnings on Thursday

AlloVir (NASDAQ:ALVR) is expected to announce its earnings results before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of ($2.76) per share for the quarter.

AlloVir Stock Performance

ALVR opened at $9.49 on Wednesday. The business has a 50 day moving average price of $9.81 and a 200 day moving average price of $13.67. AlloVir has a twelve month low of $7.96 and a twelve month high of $24.15. The firm has a market cap of $47.85 million, a P/E ratio of -0.47 and a beta of 0.63.

About AlloVir

AlloVir, Inc engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.